Ethema Health Corporation
GRST · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.03 | 0.00 | 0.00 |
| FCF Yield | 1.89% | -14.04% | -2.78% | -5.80% |
| EV / EBITDA | 35.79 | 40.80 | -476.10 | 111.56 |
| Quality | ||||
| ROIC | 2.54% | 1.02% | -2.64% | -1.05% |
| Gross Margin | 91.39% | 90.85% | 88.57% | 100.00% |
| Cash Conversion Ratio | 1.87 | 1.32 | 0.08 | 0.24 |
| Growth | ||||
| Revenue 3-Year CAGR | 41.40% | 28.23% | 17.34% | 7.67% |
| Free Cash Flow Growth | 109.60% | -429.43% | 70.58% | -117.18% |
| Safety | ||||
| Net Debt / EBITDA | 33.55 | 35.61 | -433.58 | 86.02 |
| Interest Coverage | 1.08 | 0.43 | -1.53 | -0.31 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -229.89 | -226.57 | -254.53 | 16.00 |